William Guyer - 01 Mar 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Development Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer.
Issuer symbol
CORT
Transactions as of
01 Mar 2024
Net transactions value
-$14,532
Form type
4
Filing time
05 Mar 2024, 21:09:21 UTC
Previous filing
13 Feb 2024
Next filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Tax liability $14,532 -604 -9.1% $24.06 6,039 01 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F2 Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.